CClinicalTrials.gg
CompletedNCT04680481Updated Dec 17, 2025

Non-Invasive Brain Stimulation to Control Large-Scale Brain Networks

An interventional study of Transcranial alternating current stimulation in Working Memory, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-17.

Sponsored by University of Minnesota · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was Sep 2025, 1 year 1 month ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This project will assess the feasibility of traveling wave transcranial alternating current stimulation (tACS) to modify working memory performance and large-scale brain connectivity in surgical epilepsy patients.

02

Conditions studied

  • Working Memory
03

In context

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. the patient can consent for themselves;
  2. the patient has or is scheduled for surgically implanted electrodes for the purposes of phase II epilepsy surgical evaluation;
  3. age 18+ years old;

Exclusion criteria

Exclusion Criteria:

1. diminished capacity to consent;

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Stimulation Theta Group

    Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 4 Hz (theta condition).

    Device: Transcranial alternating current stimulation

  • Experimental
    Stimulation Beta Group

    Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 23 Hz (beta condition).

    Device: Transcranial alternating current stimulation

Interventions

  • DeviceTranscranial alternating current stimulation

    Traveling wave transcranial alternating current stimulation will be applied at 4 Hz and 23 Hz over frontal and parietal brain areas in a randomized counterbalanced order.

06

What researchers measure

Primary outcomes

  1. Electrophysiological outcomes

    Changes in spectral power and coherence of the local field potentials during transcranial electric stimulation relative to no stimulation periods.

    Time frame: Immediate effect during stimulation

  2. Working memory outcomes

    Changes in working memory performance as measured with the N-back task (quantified with d-prime) during stimulation.

    Time frame: Immediate effect during stimulation

07

Study locations

1 site
  • University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data will be shared following the IRB guidelines and Data Sharing Policy for the National Institute of Mental Health (NOT-MH-19-033).

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04680481
Lead sponsor
University of Minnesota
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Dec 23, 2020
Start date
Nov 1, 2020
Primary completion
Sep 1, 2025
Completion
Sep 1, 2025
Last update
Dec 17, 2025

Study contacts

Alexander Opitz, PhD
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion